Defining and Predicting Early Recurrence after Resection for Gallbladder Cancer
- PMID: 32892270
- DOI: 10.1245/s10434-020-09108-y
Defining and Predicting Early Recurrence after Resection for Gallbladder Cancer
Abstract
Background: The optimal time interval to define early recurrence (ER) among patients who underwent resection of gallbladder cancer (GBC) is not well defined. We sought to develop and validate a novel GBC recurrence risk (GBRR) score to predict ER among patients undergoing resection for GBC.
Patients and methods: Patients who underwent curative-intent resection for GBC between 2000 and 2018 were identified from the US Extrahepatic Biliary Malignancy Consortium database. A minimum p value approach in the log-rank test was used to define the optimal cutoff for ER. A risk stratification model was developed to predict ER based on relevant clinicopathological factors and was externally validated.
Results: Among 309 patients, 103 patients (33.3%) had a recurrence at a median follow-up period of 15.1 months. The optimal cutoff for ER was defined at 12 months (p = 3.04 × 10-18). On multivariable analysis, T3/T4 disease (HR: 2.80; 95% CI 1.58-5.11) and poor tumor differentiation (HR: 1.91; 95% CI 1.11-3.25) were associated with greater hazards of ER. The GBRR score was developed using β-coefficients of variables in the final model, and patients were classified into three distinct groups relative to the risk for ER (12-month RFS; low risk: 88.4%, intermediate risk: 77.9%, high risk: 37.0%, p < 0.001). The external validation demonstrated good model generalizability with good calibration (n = 102: 12-month RFS; low risk: 94.2%, intermediate risk: 59.8%, high risk: 42.0%, p < 0.001). The GBRR score is available online at https://ktsahara.shinyapps.io/GBC_earlyrec/ .
Conclusions: A novel online calculator was developed to help clinicians predict the probability of ER after curative-intent resection for GBC. The proposed web-based tool may help in the optimization of surveillance intervals and the counselling of patients about their prognosis.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics 2016. CA: Cancer J Clin. 2016;66(1):7–30.
-
- Castro FA, Koshiol J, Hsing AW, Devesa SS. Biliary tract cancer incidence in the United States—Demographic and temporal variations by anatomic site. Int J Cancer. 2013;133(7):1664–71. - DOI
-
- Ito H, Takahashi Y, Mise Y, Inoue Y, Ishizawa T, Saiura A. Locally advanced gallbladder cancer: Contemporary outcomes for aggressive surgical management. J Clin Oncol. 2018;36(4_suppl):420. - DOI
-
- Sahara K, Tsilimigras DI, Maithel SK, et al. Survival benefit of lymphadenectomy for gallbladder cancer based on the therapeutic index: An analysis of the US extrahepatic biliary malignancy consortium. J Sur Oncol. 2020;121(3):503–10. - DOI
-
- Engineer R, Goel M, Chopra S, et al. Neoadjuvant chemoradiation followed by surgery for locally advanced gallbladder cancers: a new paradigm. Ann Surg Oncol. 2016;23(9):3009–15. - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
